4 Hot Biotech Stocks to Buy

Compugen Ltd. (NASDAQ: CGEN) is the leading bioinformatics company in the world and a pure play on the evolution of the drug discovery business. You will not see CGEN’s products at your pharmacy, but the company licenses its peptides and proteins for a fee to the who’s who of the drug industry, and also receives a back-end cut of any drug that makes it to market using its discoveries. CGEN also has some promising prospects for internal development. Of the four biotech stocks listed here, CGEN is the one that trades most in line with the market.

As with Cerus, the options on this stock are very illiquid. So consider buying the stock, currently trading around $4.80, and perhaps writing some options.